Seed

produces VS-01, a vaginal synbiotic suppository built on three specific L. crispatus strains (LUCA103, LUCA011, LUCA009) selected from a bank of over 600 candidates, validated in a randomized, double-blind, placebo-controlled trial converting 90% of participants to an optimal vaginal microbiome within 21 days.

Country
United States
vaginal-synbiotic-suppository us
Coverage
US
regenerative-personalized✓
Regulatorsfdareach
Technologies
NameClusterRisk
Bio-sexual wellness productsregenerative-personalizedLow→

Compiled by BIOECON from primary sources.

Compliance Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.